Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples – a short report
ConclusionMCAM-based flow cytometric analysis of pleural effusions is more sensitive than routine cytological analysis. Flow cytometric analysis of pleural effusions and tumor-associated CECs in peripheral blood may serve as a promising approach for the prognostication of MPM patients and, therefore, warrants further study.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Asbestosis | Cancer & Oncology | Cytology | Melanoma | Mesothelioma | Skin Cancer | Study